The latest RET news and updates
Filter
2023 RET Cancer Research Update
Read More
New clinical trial testing amivantamab
Read More
Join the email list.
Subscribe to receive info on unpublished research, current clinical trials, & general RET news.
2023 Happy Lungs Project RET Research Update
Scientific research update: Drs. John Heymach, Alexandre Drilon, and Alexandre Reuben shared the latest progress on their projects aimed at investigating new therapies for RET-inhibitor resistant disease and developing new immunotherapies for RET cancer.
RET positive lung cancer is caused by a rare mutation of the RET gene that causes cancer cells to grow out of control.
This “driver mutation” occurs in about 2% of non-small cell lung cancer patients and is more common among young never-smokers, often the mothers of school-age children.
In many cases, it isn’t diagnosed until after the cancer has spread to other organs throughout the body. The Happy Lungs Project is dedicated to curing this disease.
Help us improve the lives of tens-of-thousands of RET positive survivors and their families.
Everyone counts.
We are all in this together.
2021
Established in
5
Research Projects
1
Funding to Date
90
Members
Proudly partnering with these organizations
